Status:
NOT_YET_RECRUITING
Incremental PD With Single Icodextrin Exchange
Lead Sponsor:
RenJi Hospital
Conditions:
Peritoneal Dialysis Complication
Residual Kidney Function
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Objectives: To investigate the efficacy and safety of single daily icodextrin exchange for initiation of incremental peritoneal dialysis (PD). Subjects: Seventy-two incident PD patients. Methods: A ...
Detailed Description
Incremental peritoneal dialysis (PD) has become a more prevalently adopted strategy in incident PD patients. There is significant variation in regimens of incremental PD. Initiation of PD with a singl...
Eligibility Criteria
Inclusion
- male or female patients aged 18 to 75 years;
- patients with chronic kidney disease stage 5 who are to start PD;
- eGFR ≥ 5 ml/min;
- urine output ≥ 800 ml/d.
Exclusion
- documented anaphylaxis with icodextrin or glucose-based dialysate;
- concomitant severe chronic diseases such as malignancy, hepatitis, severe cardiac diseases, etc.;
- ongoing severe infection;
- planned or ongoing pregnancy or lactation;
- currently enrolled in other clinical studies;
- patients who have a life expectancy of \<12 months;
- refusal to give a written consent.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06119373
Start Date
December 1 2023
End Date
November 30 2026
Last Update
November 8 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.